Recombinant Human ALDH1A2 (N-6His)

Description

EnkiLife provides the Recombinant Human ALDH1A2 (N-6His) protein,aslo know as Aldehyde dehydrogenase family 1 member A2,Retinaldehyde-specific dehydrogenase type 2,RALDH(II),Retinal dehydrogenase 2,ALDH1A2,RALDH2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Aldehyde Dehydrogenase Family 1 Member A2 is produced by our E.coli expression system and the target gene encoding Met1-Ser518 is expressed with a 6His tag at the N-terminus.Accession:O94788. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:58.2 KDa. Background:Aldehyde dehydrogenase 1 family member A2 (ALDH1A2), also known as retinaldehyde dehydrogenase 2 (RALDH2), belongs to the aldehyde dehydrogenase family which contains two members, the ALDH1 s (ALDH1A1, ALDH1A2 and ALDH1A3) and the 9-cis retinaldehyde dehydrogenase ALDH8 s. ALDH1A2 is key enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. RA is a paracrine hormone signaling molecule that functions in developing and adult tissues. ALDH1A2 was also found to regulate normal and tumor cell growth and differentiation. Several studies showed that ALDH1A2 expression is increased after the appearance of AraC resistance in clinical cases which means this protein is effective in AraC resistance.